Abstract:Abstract Background RSV is a major cause of pediatric respiratory disease. Antibodies to the prefusion conformation of the RSV fusion (pre-F) protein are needed for virus neutralization. Method We measured RSV-specific responses in two groups of children <3 years of age; subjects with laboratory-confirmed RSV (RSV-infected) or infants born in the period May to September and enrolled prior to their first RSV season (RSV-uninfected). RSV-infected infants had blood samples obtained at 1, 6, 9, and 12 months after infection. RSV-uninfected infants had blood samples obtained at enrollment, at the end of their first RSV season, and 6 months later. A kELISA to measure RSV pre-F-specific antibodies and an RBF assay to identify RSV F-specific B cells were developed. Results 102 subjects were enrolled; 11 were excluded due to missed visits or withdrawal. Of the 65 subjects in the RSV-uninfected group, all were kELISA positive at enrollment, consistent with maternal antibody transfer. 53 subjects had sufficient samples for analysis at multiple time points; 29 became seronegative and 24 remained seropositive. In the seronegative group, the kELISA value decreased rapidly to <0.25 by 6 months after the RSV season in 27/29 (93%), (Figure 1a). In the persistently seropositive group, all 24 subjects maintained a positive kELISA value, with some developing higher values over time, consistent with asymptomatic infection (Figure 1b). An RBF assay was used to determine whether antibodies were due to persistent maternal antibodies or endogenous production (Figure 1c). In the seronegative group, 24/29 (80%) had a negative RBF; in the seropositive group, 23/24 (96%) had a positive RBF during follow-up. There were 26 subjects in the RSV-infected group; 22 had sufficient samples for analysis at multiple time points. All were seropositive by kELISA at one month post-infection with variable kELISA values during follow-up (Figure 1d). 17/22 (77%) had a positive RBF, although 4 of the subjects without a positive RBF had indeterminate results at ≥ 1 visit. Conclusion Assays measuring F-specific immune responses in infants will be critical for RSV vaccine development. A kELISA targeting RSV pre-F epitopes, with an RBF assay targeting RSV F-specific B cells, may allow discrimination for maternal and infant-derived antibodies.

Use of flow cytometry to investigate the cytokine response pattern in infants with respiratory syncytial virus infection and bronchiolitis

Association of Cytokine Responses with Disease Severity in Infants with Respiratory Syncytial Virus Infection

Epidemiological Characteristics and Immune Status of Children with Respiratory Syncytial Virus.

[Airway Inflammation Induced by Poly(I:C) Stimulation in the Late Stage of Respiratory Syncytial Virus Infection in Mice and Its Mechanism].

[Changes and the Clinical Significance of CD4⁺ CD25⁺ Regulatory T Cells and Th17 Cells in Peripheral Blood of Infants with Respiratory Syncytial Virus Bronchiolitis].

Study of T-helper Cell Function in Infants with Respiratory Syncyt Ial Virus Lower Respiratory Tract Infection

The study of T-helper cell subpopulation Th1/Th2 and cytokine IFN-γ,IL-4 for infants with RSV LRTIs

Neutrophil Activation and Protease Imbalance in Respiratory Tract of Infants with Respiratory Syncytial Virus Bronchiolitis

Relationship Between Respiratory Syncytial Virus Bronchiolitis and Bronchial Asthma

Analysis on Lymphocyte Subsets in Children with Acute Respiratory Syncytial Virus Lower Respiratory Tract Infection

The role of TH1 cell in respiratory syncytial virus bronchiolitis

Changes in T-Cell Subsets and Serum IFN-γ, IL-17, and IgE Levels in Children with Respiratory Syncytial Virus Capillary Bronchitis and Their Clinical Significance

The CD4 T cell response to respiratory syncytial virus infection

#11 Development of a Kinetic ELISA (kELISA) and Reactive B Cell Frequency (RBF) Assay to Detect Respiratory Syncytial Virus (RSV) Pre-Fusion F Protein-Specific Immune Responses in Infants

The Role of Peripheral Type 2 Innate Lymphoid Cells in Bronchiolitis

Pulmonary function changes in infants with respiratory syncytial virus or mycoplasma pneumoniae infection and clinical significance

Analysis of Immune Function in Children with Pneumonia of RSV or SP Infection

Changes and significance of cytokine profiles in children with respiratory tract infection of human metapneumovirus or respiratory syncytial virus

Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections

Inhibition of NF-κB/IL-33/ST2 Axis Ameliorates Acute Bronchiolitis Induced by Respiratory Syncytial Virus

Expression of interferon regulatory factor-1 and Th1/Th2 imbalance in lung of respiratory syncytial virus infected rats